Guggenheim analyst Etzer Darout lowered the firm’s price target on Inventiva (IVA) to $9 from $12 and keeps a Buy rating on the shares. With the company now funded through topline due data in the second half of 2026, the firm updated its model based on recent MASH market trends and pricing, offset by greater marketing spend and a fully diluted share count based on the Structured Financing agreement, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IVA:
- 3 Best Stocks to Buy Now, 4/4/2025, According to Top Analysts
- Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright
- Inventiva’s Strategic Advancements and Financial Strength Bolster Buy Rating
- Inventiva’s Strategic Advancements and Financial Positioning Drive Buy Rating
- Inventiva’s Promising Future: Buy Rating Backed by Phase III Milestone and Financial Stability